Ezekiel Weis

Ezekiel Weis

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2006 in Archives of Ophthalmology (1950)
Verified
Journal Article
Open access
PDF file
EWEzekiel Weis
Ezekiel Weis
CSChirag P. Shah
Chirag P. Shah
MLMartin Lajous
Martin Lajous
JSJerry A. Shields
Jerry A. Shields
CSCarol L. Shields
Carol L. Shields
Choroidal melanoma is the most common primary intraocular malignancy in white individuals in the United States and Europe.1 The choroid is the second most common site for melanoma after cutaneous melanoma.1 Cutaneous melanoma has an annual incidence of 12.2 to 48.1 persons per 100 000,2 whereas uveal melanoma has an annual incidence of 6 persons per million.3

1 September 2005 in Ophthalmology
Verified
Journal Article
Closed access
CSChirag P. Shah
Chirag P. Shah
EWEzekiel Weis
Ezekiel Weis
MLMartin Lajous
Martin Lajous
JSJerry A. Shields
Jerry A. Shields
CSCarol L. Shields
Carol L. Shields

1 August 2009 in Archives of Ophthalmology (1950)
Verified
Journal Article
Closed access
PDF file
EWEzekiel Weis
Ezekiel Weis
JRJack Rootman
Jack Rootman
TJThomas J. Joly
Thomas J. Joly
KBKenneth W. Berean
Kenneth W. Berean
HAHind M. Al-Katan
Hind M. Al-Katan
VWValerie A. White
Valerie A. White
Research from JAMA Ophthalmology — Epithelial Lacrimal Gland Tumors — Pathologic Classification and Current Understanding

1 June 2009 in Ophthalmology
Verified
Journal Article
Closed access
SAS. Mehdi Ahmad
S. Mehdi Ahmad
BEBita Esmaeli
Bita Esmaeli
MWMichelle Williams
Michelle Williams
JNJohn Nguyen
John Nguyen
AFAaron Fay
Aaron Fay
ALAdriana Lopez
Adriana Lopez

1 September 2007 in Ophthalmology
Verified
Journal Article
Closed access
CRChristopher J. Rudnisky
Christopher J. Rudnisky
MTMatthew T.S. Tennant
Matthew T.S. Tennant
EWEzekiel Weis
Ezekiel Weis
ATAndrew Ting
Andrew Ting
BHBradley J. Hinz
Bradley J. Hinz
MGMark D.J. Greve
Mark D.J. Greve

1 December 1999 in Archives of Ophthalmology (1950)
Verified
Journal Article
Open access
PDF file
MLMark Linder
Mark Linder
TCTom S. Chang
Tom S. Chang
ISIngrid U. Scott
Ingrid U. Scott
DHDawn Hay
Dawn Hay
KCKeith Chambers
Keith Chambers
EWEzekiel Weis
Ezekiel Weis
SNELLEN VISUAL acuity is the most widely used measure of visual function. Other measures, including contrast sensitivity,1,2 visual field,1,3,4 and glare testing,1,2 have demonstrated that visual acuity is a descriptor of a single aspect of vision rather than a comprehensive assessment of visual function. An approach that is gaining popularity is the use of standardized vision-related quality-of-life instruments to measure the functional visual status of patients. This variable may be used with other vision descriptors to monitor individual patient progress in clinical settings and clinical trials. Several such instruments have been developed.5-7